I’ve spent a long time believing I wrote this column for other people — for anyone trying to build a decent life with chronic obstructive pulmonary disease (COPD), who wakes up each morning negotiating with their own lungs. While that’s still part of it, lately, I’ve realized something I…
A novel test based on the levels and composition of certain proteins in mucus, called mucins, may help assess lung health in people with chronic obstructive pulmonary disease (COPD), according to a new study. Findings show that higher Mucin Quantitative Score (MUCQ) values were significantly associated with worse lung…
The first person with chronic obstructive pulmonary disease (COPD) has now been dosed with BBT002, an experimental medication being developed by Bambusa Therapeutics, in an ongoing Phase 1b clinical trial. The trial (NCT06944925) is evaluating BBT002’s safety and pharmacological properties against a placebo in up to 98…
Mabwell’s experimental therapy 9MW1911 may reduce the frequency of moderate to severe exacerbations in people with chronic obstructive pulmonary disease (COPD), according to data from a completed Phase 2a clinical trial. The results were announced in a press release from Mabwell. The company is now conducting a…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
